Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Novo Nordisk on Monday also pulled its bid for Metsera, allowing Pfizer to acquire the company for $10 billion and ending the bidding war
These products are not approved for human consumption, self-administration, or any therapeutic, clinical, or veterinary application
No cases of severe injection-site necrosis, abscess, or infection were documented, and there was no evidence of cumulative worsening with repeated doses over time
The trial plans to enroll 3,300 cognitively healthy people aged 5055 years who are at high risk of AD, as determined by elevated plasma pTau217 levels and Telephone Interview for Cognitive Status-modified scores
The core of this litigation targets major pharmaceutical companies, Novo Nordisk and Eli Lilly and Co., accusing them of failing to sufficiently warn users about the severe digestive side effects of GLP-1 class drugs, typically prescribed for diabetes management and weight loss
US$ 23.14
US$ 27.28
US$ 24.79
US$ 27.64
US$ 27.96
